한국관련자료
Harm reduction and its role in improving health outcomes in an era of fentanyl
Harm reduction, as a philosophical approach where people who use drugs are treated without shame or stigma, can be integrated into treatment and other needed services. Specific harm reduction services may include drug testing kits, syringes to reduce the risk of infectious disease, overdose prevention facilities, and overdose reversal medications for those who may witness an overdose. These programs also provide referrals or direct services that address medical needs and social determinants of health, such as housing, nutrition, legal services, and employment. The services provided at harm reduction facilities adapt to the needs of local communities and continuously evolve.
However, even during an epidemic of overdose deaths, stigma, regulatory barriers, and funding challenges limit access to harm reduction services. Obstacles include funding and operating restrictions, community opposition, and legal prohibitions. Harm reduction services are embedded into the continuum of care, helping to mitigate the negative consequences associated with drug use and improving long-term health outcomes. To deliver these services effectively, policymakers must address racial, ethnic, and other disparities in communities at the greatest risk. Delivering harm reduction at scale requires bridging the gap between service availability and service needs. Leadership must be agile, focusing on providing sustainable, evidence-based, and equitable services amid rapidly changing policy, legal, and drug supply environments.
However, even during an epidemic of overdose deaths, stigma, regulatory barriers, and funding challenges limit access to harm reduction services. Obstacles include funding and operating restrictions, community opposition, and legal prohibitions. Harm reduction services are embedded into the continuum of care, helping to mitigate the negative consequences associated with drug use and improving long-term health outcomes. To deliver these services effectively, policymakers must address racial, ethnic, and other disparities in communities at the greatest risk. Delivering harm reduction at scale requires bridging the gap between service availability and service needs. Leadership must be agile, focusing on providing sustainable, evidence-based, and equitable services amid rapidly changing policy, legal, and drug supply environments.
많이 본 자료
![[팀튜링의 디지털 오디세이] 제1화 UAM의 미래](/userdata/main/incContent/sideLink/19/aaaGHKBjsPPI5g31szc-y20240605110816byhta.png)
![[2024.04] 물가상승](/userdata/main/incContent/sideLink/20/aaaGHKBjsPPI5g31szc-y20240605111046bpogp.jpg)
